REPRIEVE Study
Protecting One's Heart
The REPRIEVE study aims to prevent cardiovascular disease
by Chael Needle
As people are living longer with HIV, researchers have been increasingly attending to...
PRO 140
Chronic Relief?
A self-injectable monoclonal antibody vies to become a monotherapy
by Chael Needle
Anti-HIV agents currently being researched these days seem split between (1) improving regimens...
Vpu Inhibitor Candidate
BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....
Calling Out the Media’s Racism & Xenophobia: HIV Is Not a...
Color Blind
A new report documents racism and xenophobia in HIV non-disclosure media coverage in Canada
by Larry Buhl
A new report documents the anti-Black and anti-immigrant...
Finding Relief
Approximately thirty to sixty percent of people living with HIV and on antiretroviral therapy (ARVs) experience diarrhea. Reoccurring and frequent diarrhea is often reluctantly...
Microbes & HIV
Working Toward Balance
Research into treating the effects of microbes gains steam
by Jeannie Wraight
There’s been lots of talk recently about the importance of microbes on...
Transcendental Meditation
State of Mind
Got stress? Explore transcendental meditation
by Robert Zukowski
We have talked at length about complementary, alternative and integrative options that impact the body, our...
Revisiting Immunity
NAPWA helps to promote immune-based therapies
by Chael Needle
At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...
Think Positive
Not long ago I was seeking out new and interesting options for continuing education to add to my existing practice. In my travels, I...
Black Treatment Advocates Network
Wellness Watch by Chael Needle
Sustain & Maintain
With the help of A. Toni Young & CEG, the Black Treatment Advocates Network rolls out in D.C.
"We...
















